Patient Guide: Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 175 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT03924856
Status: ACTIVE_NOT_RECRUITING
Condition: Bladder Cancer
Phase: PHASE3

Find a Study Location Near You

This study is available at 175 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • La Jolla, California
  • Santa Monica, California
  • Washington D.C., District of Columbia
  • • And 172 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily